Rare diseases
Investigational molecules
Locations
Back to Poland45 clinical trials in Myslowice, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis
PolandStudy on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease
PolandStudy of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis
PolandPhase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes
PolandEfficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes
PolandSafety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH
PolandPolandStudy of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)
PolandSafety and Efficacy of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis: A Long‑Term Randomized Placebo‑Controlled Study
PolandStudy on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3
PolandStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
PolandStudy on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis, evaluating novel therapeutic approaches and treatments. Studies are examining the safety and efficacy of experimental medications for these chronic liver conditions.
Advanced clinical trials investigating treatments for Hepatocellular Carcinoma and Non-Muscle Invasive Bladder Cancer. Studies are evaluating combination therapies and immunotherapy approaches to improve patient outcomes.
Innovative research on Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis (NASH). Studies are exploring new combination therapies and investigating treatments for liver complications associated with metabolic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
